Johanne Kaplan serves as Chief Development Officer at ProMIS Neurosciences Inc., where they oversee executive responsibilities. Since joining the company, Johanne Kaplan has executed 3 insider transactions totaling $25.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 19, 2026 involved purchasing 1,629 shares valued at $25.0K.
Johanne Kaplan currently holds 3,941 shares of ProMIS Neurosciences Inc. (PMN), valued at approximately $0. This represents their equity stake as Chief Development Officer.
Based on SEC Form 4 filings, Johanne Kaplan has been a net buyer of PMN stock. They have purchased $25.0K and sold $0 worth of shares.
Johanne Kaplan's most recent insider trade was on Feb 19, 2026, when they purchased 1,629 shares at $15.35 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 3, 2026 | PMN | $25.0K | Award | 2,060 | $12.13 | Discretionary |